SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni

Anne Mette Hvas; Sisse Rye Ostrowski; Henrik Frederiksen; Peter Kampmann; Jakob Stensballe

SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni

Translated title of the contribution: SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia

Anne Mette Hvas^*, Sisse Rye Ostrowski, Henrik Frederiksen, Peter Kampmann, Jakob Stensballe

^*Corresponding author for this work

1 Citation (Scopus)

Abstract

Vaccine-induced immune thrombosis and thrombocytopenia (VITT) is a new syndrome, which has emerged after introduction of the adenovirus vector-based COVID-19 vaccines ChAdOx1 nCoV-19 og Ad26.COV2-SVITT is characterised by venous thrombosis at unusual, and often multiple localisations, especially including cerebral venous sinus thrombosis. Besides, bleeding manifestations often occur. Biochemically, VITT is characterised by thrombocytopaenia and elevated fibrin d-dimer. VITT is a rapidly progressing and potentially life-threatening syndrome where rapid diagnosis and treatment are essential as argued in this review.

Translated title of the contribution	SARS-CoV-2 vaccine-induced immune thrombosis and thrombocytopenia
Original language	Danish
Article number	V05210473
Journal	Ugeskrift for Laeger
Volume	183
Issue number	18
Number of pages	8
ISSN	0041-5782
Publication status	Published - 19 Jul 2021

Cite this

@article{832ded9591f247cbb2ce26df0f1e4455,

title = "SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni",

abstract = "Vaccine-induced immune thrombosis and thrombocytopenia (VITT) is a new syndrome, which has emerged after introduction of the adenovirus vector-based COVID-19 vaccines ChAdOx1 nCoV-19 og Ad26.COV2-SVITT is characterised by venous thrombosis at unusual, and often multiple localisations, especially including cerebral venous sinus thrombosis. Besides, bleeding manifestations often occur. Biochemically, VITT is characterised by thrombocytopaenia and elevated fibrin d-dimer. VITT is a rapidly progressing and potentially life-threatening syndrome where rapid diagnosis and treatment are essential as argued in this review.",

keywords = "COVID-19, COVID-19 Vaccines, Humans, SARS-CoV-2, Thrombocytopenia/chemically induced, Thrombosis, Vaccines",

author = "Hvas, \{Anne Mette\} and Ostrowski, \{Sisse Rye\} and Henrik Frederiksen and Peter Kampmann and Jakob Stensballe",

year = "2021",

month = jul,

day = "19",

language = "Dansk",

volume = "183",

journal = "Ugeskrift for Laeger",

issn = "0041-5782",

publisher = "Almindelige Danske L{\ae}geforening",

number = "18",

}

TY - JOUR

T1 - SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni

AU - Hvas, Anne Mette

AU - Ostrowski, Sisse Rye

AU - Frederiksen, Henrik

AU - Kampmann, Peter

AU - Stensballe, Jakob

PY - 2021/7/19

Y1 - 2021/7/19

N2 - Vaccine-induced immune thrombosis and thrombocytopenia (VITT) is a new syndrome, which has emerged after introduction of the adenovirus vector-based COVID-19 vaccines ChAdOx1 nCoV-19 og Ad26.COV2-SVITT is characterised by venous thrombosis at unusual, and often multiple localisations, especially including cerebral venous sinus thrombosis. Besides, bleeding manifestations often occur. Biochemically, VITT is characterised by thrombocytopaenia and elevated fibrin d-dimer. VITT is a rapidly progressing and potentially life-threatening syndrome where rapid diagnosis and treatment are essential as argued in this review.

AB - Vaccine-induced immune thrombosis and thrombocytopenia (VITT) is a new syndrome, which has emerged after introduction of the adenovirus vector-based COVID-19 vaccines ChAdOx1 nCoV-19 og Ad26.COV2-SVITT is characterised by venous thrombosis at unusual, and often multiple localisations, especially including cerebral venous sinus thrombosis. Besides, bleeding manifestations often occur. Biochemically, VITT is characterised by thrombocytopaenia and elevated fibrin d-dimer. VITT is a rapidly progressing and potentially life-threatening syndrome where rapid diagnosis and treatment are essential as argued in this review.

KW - COVID-19

KW - COVID-19 Vaccines

KW - Humans

KW - SARS-CoV-2

KW - Thrombocytopenia/chemically induced

KW - Thrombosis

KW - Vaccines

UR - https://www.scopus.com/pages/publications/85114068937

M3 - Tidsskriftartikel

C2 - 34356021

SN - 0041-5782

VL - 183

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 18

M1 - V05210473

ER -

SARS-CoV-2-vaccineinduceret immuntrombose og trombocytopeni

Abstract

Other files and links

Fingerprint

Cite this